• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SC 13G/A filed by Chemours Company

    11/12/24 9:55:16 AM ET
    $CC
    Major Chemicals
    Industrials
    Get the next $CC alert in real time by email
    SC 13G/A 1 filing.txt SCHEDULE 13G Amendment No.11 CHEMOURS CO COMMON STOCK Cusip #163851108 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) Cusip #163851108 Item 1: Reporting Person - FMR LLC Item 2: (a) [ ] (b) [ ] Item 4: Delaware Item 5: 17,291,941 Item 6: 0 Item 7: 18,028,524 Item 8: 0 Item 9: 18,028,524 Item 11: 12.077% Item 12: HC Cusip #163851108 Item 1: Reporting Person - Abigail P. Johnson Item 2: (a) [ ] (b) [ ] Item 4: United States of America Item 5: 0 Item 6: 0 Item 7: 18,028,524 Item 8: 0 Item 9: 18,028,524 Item 11: 12.077% Item 12: IN Item 1(a). Name of Issuer: CHEMOURS CO Item 1(b). Address of Issuer's Principal Executive Offices: 1007 MARKET STREET WILMINGTON, DE 19801 USA Item 2(a). Name of Person Filing: FMR LLC Item 2(b). Address or Principal Business Office or, if None, Residence: 245 Summer Street, Boston, Massachusetts 02210 Item 2(c). Citizenship: Not applicable Item 2(d). Title of Class of Securities: COMMON STOCK Item 2(e). CUSIP Number: 163851108 Item 3. This statement is filed pursuant to Rule 13d-1(b) or 13d-2(b) or (c) and the person filing, FMR LLC, is a parent holding company in accordance with Section 240.13d-1(b)(1)(ii)(G). (Note: See Exhibit A). Item 4. Ownership (a) Amount Beneficially Owned: 18,028,524 (b) Percent of Class: 12.077% (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: Please see the responses to Items 5 and 6 on the cover page (ii) shared power to vote or to direct the vote: 0 (iii) sole power to dispose or to direct the disposition of: 18,028,524 (iv) shared power to dispose or to direct the disposition of: 0 Item 5. Ownership of Five Percent or Less of a Class. Not applicable. Item 6. Ownership of More than Five Percent on Behalf of Another Person. One or more other persons are known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the COMMON STOCK of CHEMOURS CO. No one other person's interest in the COMMON STOCK of CHEMOURS CO is more than five percent of the total outstanding COMMON STOCK. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. See attached Exhibit A. Item 8. Identification and Classification of Members of the Group. Not applicable. Item 9. Notice of Dissolution of Group. Not applicable. Item 10. Certifications. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. Signature After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. November 8, 2024 Date /s/ Stephanie J. Brown Signature Stephanie J. Brown Duly authorized under Power of Attorney effective as of January 3, 2023, by and on behalf of FMR LLC and its direct and indirect subsidiaries* * This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on January 10, 2023, accession number: 0000315066-23-000003. Exhibit A Pursuant to the instructions in Item 7 of Schedule 13G, the following table lists the identity and Item 3 classification, if applicable, of each relevant entity that beneficially owns shares of the security class being reported on this Schedule 13G. Entity ITEM 3 Classification FIAM LLC IA Fidelity Institutional Asset Management Trust Company BK Fidelity Management & Research Company LLC * IA Strategic Advisers LLC IA * Entity beneficially owns 5% or greater of the outstanding shares of the security class being reported on this Schedule 13G. Abigail P. Johnson is a Director, the Chairman and the Chief Executive Officer of FMR LLC. Members of the Johnson family, including Abigail P. Johnson, are the predominant owners, directly or through trusts, of Series B voting common shares of FMR LLC, representing 49% of the voting power of FMR LLC. The Johnson family group and all other Series B shareholders have entered into a shareholders' voting agreement under which all Series B voting common shares will be voted in accordance with the majority vote of Series B voting common shares. Accordingly, through their ownership of voting common shares and the execution of the shareholders' voting agreement, members of the Johnson family may be deemed, under the Investment Company Act of 1940, to form a controlling group with respect to FMR LLC. This filing reflects the securities beneficially owned, or that may be deemed to be beneficially owned, by FMR LLC, certain of its subsidiaries and affiliates, and other companies (collectively, the "FMR Reporters"). This filing does not reflect securities, if any, beneficially owned by certain other companies whose beneficial ownership of securities is disaggregated from that of the FMR Reporters in accordance with Securities and Exchange Commission Release No. 34-39538 (January 12, 1998). RULE 13d-1(k)(1) AGREEMENT The undersigned persons, on November 8, 2024, agree and consent to the joint filing on their behalf of this Schedule 13G in connection with their beneficial ownership of the COMMON STOCK of CHEMOURS CO at September 30, 2024. FMR LLC By /s/ Stephanie J. Brown Stephanie J. Brown Duly authorized under Power of Attorney effective as of January 3, 2023, by and on behalf of FMR LLC and its direct and indirect subsidiaries* Abigail P. Johnson By /s/ Stephanie J. Brown Stephanie J. Brown Duly authorized under Power of Attorney effective as of January 26, 2023, by and on behalf of Abigail P. Johnson** * This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on January 10, 2023, accession number: 0000315066-23-000003. ** This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on January 31, 2023, accession number: 0000315066-23-000038.
    Get the next $CC alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CC

    DatePrice TargetRatingAnalyst
    3/27/2025$19.00Neutral → Outperform
    Mizuho
    1/28/2025$27.00Buy
    Truist
    7/9/2024$28.00 → $30.00Neutral → Buy
    UBS
    6/7/2024$25.00Neutral
    Mizuho
    4/9/2024$19.00 → $34.00Underperform → Outperform
    BMO Capital Markets
    3/5/2024$37.00 → $21.00Buy → Neutral
    UBS
    2/29/2024$45.00 → $19.00Outperform → Underperform
    BMO Capital Markets
    12/1/2023$28.00 → $40.00Sector Perform → Outperform
    RBC Capital Mkts
    More analyst ratings

    $CC
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • The Chemours Company Provides Update on Second Quarter 2025 Outlook

      The Chemours Company (Chemours) (NYSE:CC), a global chemistry company with leading market positions in Thermal & Specialized Solutions (TSS), Titanium Technologies (TT), and Advanced Performance Materials (APM), today provided an update on its second quarter 2025 outlook. For the second quarter of 2025, due to better-than-expected performance, TSS now anticipates a sequential increase in Net Sales of approximately 25% driven by strong demand for Opteon™ Refrigerants, in connection with the stationary transition to low global warming potential refrigerants under the U.S. AIM Act. Consistent with this increased demand, TSS also projects a sequential increase in Adjusted EBITDA of nearly 40%

      6/18/25 6:45:00 AM ET
      $CC
      Major Chemicals
      Industrials
    • Chemours Appoints Matthew Conti as Chief Human Resources Officer

      Seasoned HR executive supports Chemours' Pathway to Thrive strategy The Chemours Company (Chemours) (NYSE:CC), a global chemistry company with leading market positions in Thermal & Specialized Solutions (TSS), Titanium Technologies (TT), and Advanced Performance Materials (APM), today announced the appointment of Matthew Conti as Chief Human Resources Officer (CHRO), effective June 2. His appointment follows an extensive external search to identify a leader who will drive Chemours' people and culture strategy. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250612880421/en/Chemours appoints Matthew Conti as Chief Human Resource

      6/12/25 4:30:00 PM ET
      $CC
      Major Chemicals
      Industrials
    • Chemours Appoints Industry Vet Nathan Blom as Vice President of Liquid Cooling Growth Portfolio

      The Chemours Company ("Chemours") (NYSE:CC), a global chemistry company, announced the appointment of Nathan Blom as Vice President of its liquid cooling portfolio, effective June 9, 2025. With Blom's wealth of technology and data center experience, his addition reinforces Chemours' commitment to driving near- and long-term growth in the liquid cooling market. Bringing over two decades of experience in executive leadership, business transformation, and go-to-market strategy across the technology and data center infrastructure sectors, Blom is a strong addition to Chemours leadership. The appointment supports the company's "Pathway to Thrive" strategy, with liquid cooling representing a ke

      6/10/25 6:45:00 AM ET
      $CC
      Major Chemicals
      Industrials

    $CC
    SEC Filings

    See more
    • SEC Form SCHEDULE 13G filed by Chemours Company

      SCHEDULE 13G - Chemours Co (0001627223) (Subject)

      6/10/25 4:00:13 PM ET
      $CC
      Major Chemicals
      Industrials
    • Amendment: SEC Form SCHEDULE 13G/A filed by Chemours Company

      SCHEDULE 13G/A - Chemours Co (0001627223) (Subject)

      6/6/25 10:03:48 AM ET
      $CC
      Major Chemicals
      Industrials
    • SEC Form SD filed by Chemours Company

      SD - Chemours Co (0001627223) (Filer)

      5/29/25 4:35:48 PM ET
      $CC
      Major Chemicals
      Industrials

    $CC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Officer Gumpel Damian bought $201,376 worth of shares (21,222 units at $9.49), increasing direct ownership by 19% to 131,701 units (SEC Form 4)

      4 - Chemours Co (0001627223) (Issuer)

      6/4/25 8:32:18 PM ET
      $CC
      Major Chemicals
      Industrials
    • Chief Financial Officer Hostetter Shane bought $50,196 worth of shares (4,450 units at $11.28), increasing direct ownership by 8% to 59,694 units (SEC Form 4)

      4 - Chemours Co (0001627223) (Issuer)

      5/21/25 5:13:57 PM ET
      $CC
      Major Chemicals
      Industrials

    $CC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Officer Gumpel Damian bought $201,376 worth of shares (21,222 units at $9.49), increasing direct ownership by 19% to 131,701 units (SEC Form 4)

      4 - Chemours Co (0001627223) (Issuer)

      6/4/25 8:32:18 PM ET
      $CC
      Major Chemicals
      Industrials
    • Chief Financial Officer Hostetter Shane bought $50,196 worth of shares (4,450 units at $11.28), increasing direct ownership by 8% to 59,694 units (SEC Form 4)

      4 - Chemours Co (0001627223) (Issuer)

      5/21/25 5:13:57 PM ET
      $CC
      Major Chemicals
      Industrials
    • Director Cowan Alister was granted 14,096 shares, increasing direct ownership by 65% to 35,831 units (SEC Form 4)

      4 - Chemours Co (0001627223) (Issuer)

      4/24/25 5:36:51 PM ET
      $CC
      Major Chemicals
      Industrials

    $CC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Chemours upgraded by Mizuho with a new price target

      Mizuho upgraded Chemours from Neutral to Outperform and set a new price target of $19.00

      3/27/25 8:05:02 AM ET
      $CC
      Major Chemicals
      Industrials
    • Truist initiated coverage on Chemours with a new price target

      Truist initiated coverage of Chemours with a rating of Buy and set a new price target of $27.00

      1/28/25 7:09:50 AM ET
      $CC
      Major Chemicals
      Industrials
    • Chemours upgraded by UBS with a new price target

      UBS upgraded Chemours from Neutral to Buy and set a new price target of $30.00 from $28.00 previously

      7/9/24 8:13:51 AM ET
      $CC
      Major Chemicals
      Industrials

    $CC
    Leadership Updates

    Live Leadership Updates

    See more
    • Chemours Appoints Matthew Conti as Chief Human Resources Officer

      Seasoned HR executive supports Chemours' Pathway to Thrive strategy The Chemours Company (Chemours) (NYSE:CC), a global chemistry company with leading market positions in Thermal & Specialized Solutions (TSS), Titanium Technologies (TT), and Advanced Performance Materials (APM), today announced the appointment of Matthew Conti as Chief Human Resources Officer (CHRO), effective June 2. His appointment follows an extensive external search to identify a leader who will drive Chemours' people and culture strategy. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250612880421/en/Chemours appoints Matthew Conti as Chief Human Resource

      6/12/25 4:30:00 PM ET
      $CC
      Major Chemicals
      Industrials
    • Chemours Appoints Industry Vet Nathan Blom as Vice President of Liquid Cooling Growth Portfolio

      The Chemours Company ("Chemours") (NYSE:CC), a global chemistry company, announced the appointment of Nathan Blom as Vice President of its liquid cooling portfolio, effective June 9, 2025. With Blom's wealth of technology and data center experience, his addition reinforces Chemours' commitment to driving near- and long-term growth in the liquid cooling market. Bringing over two decades of experience in executive leadership, business transformation, and go-to-market strategy across the technology and data center infrastructure sectors, Blom is a strong addition to Chemours leadership. The appointment supports the company's "Pathway to Thrive" strategy, with liquid cooling representing a ke

      6/10/25 6:45:00 AM ET
      $CC
      Major Chemicals
      Industrials
    • DoorDash, TKO Group Holdings, Williams-Sonoma and Expand Energy Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600

      NEW YORK, March 7, 2025 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, March 24, to coincide with the quarterly rebalance. The changes ensure each index is more representative of its market capitalization range. All companies being added to the S&P 100 are more representative of the mega-cap market space. All companies being added to the S&P 500 are more representative of the large-cap market space, all companies being added to the S&P MidCap 400 are more representative of the mid-cap market space, and all companies being added to the S&P

      3/7/25 6:19:00 PM ET
      $ALK
      $AMBC
      $ATI
      $BBWI
      Air Freight/Delivery Services
      Consumer Discretionary
      Property-Casualty Insurers
      Finance

    $CC
    Financials

    Live finance-specific insights

    See more
    • Chemours Announces Dates for First Quarter 2025 Earnings Release and Webcast Conference Call

      The Chemours Company ("Chemours" or "the Company") (NYSE:CC) today announced that the Company expects to issue its first quarter 2025 financial results after market on Tuesday, May 6, 2025. The Company expects to hold its conference call to discuss its first quarter 2025 financial results at 8:00 a.m. Eastern Daylight Time on Wednesday, May 7, 2025. The call is open to the public and can be accessed via the webcast information below. Conference Call: Please visit investors.chemours.com for a link to the live webcast and to view the accompanying slides. Replay: A webcast replay will be available at investors.chemours.com. About The Chemours Company The Chemours Company (NYSE:CC) is a glo

      4/16/25 4:30:00 PM ET
      $CC
      Major Chemicals
      Industrials
    • Chemours Announces First Quarter Dividend

      The Chemours Company ("Chemours") (NYSE:CC) today announced the Board of Directors of Chemours declared a quarterly cash dividend of $0.25 per share on the Company's common stock for the first quarter of 2025. The dividend will be paid on March 14, 2025, to stockholders of record as of the close of business on February 28, 2025. About The Chemours Company The Chemours Company (NYSE:CC) is a global leader in providing industrial and specialty chemicals products for markets, including coatings, plastics, refrigeration and air conditioning, transportation, semiconductor and advanced electronics, general industrial, and oil and gas. Through our three businesses – Thermal & Specialized Solut

      2/14/25 4:30:00 PM ET
      $CC
      Major Chemicals
      Industrials
    • Chemours Announces Dates for Fourth Quarter 2024 Earnings Release and Webcast Conference Call

      The Chemours Company ("Chemours" or "the Company") (NYSE:CC) today announced that the Company expects to issue its fourth quarter 2024 financial results before market on Tuesday, February 18, 2025. The Company expects to hold its conference call to discuss its fourth quarter 2024 financial results at 8:00 a.m. Eastern Standard Time on Tuesday, February 18, 2025. The call is open to the public and can be accessed via the webcast information below. Conference Call: Please visit investors.chemours.com for a link to the live webcast and to view the accompanying slides. Replay: A webcast replay will be available at investors.chemours.com. About The Chemours Company The Chemours Company (

      2/3/25 4:30:00 PM ET
      $CC
      Major Chemicals
      Industrials

    $CC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Chemours Company

      SC 13G/A - Chemours Co (0001627223) (Subject)

      11/12/24 9:55:16 AM ET
      $CC
      Major Chemicals
      Industrials
    • SEC Form SC 13G/A filed by Chemours Company (Amendment)

      SC 13G/A - Chemours Co (0001627223) (Subject)

      2/9/24 8:50:19 AM ET
      $CC
      Major Chemicals
      Industrials
    • SEC Form SC 13G/A filed by Chemours Company (Amendment)

      SC 13G/A - Chemours Co (0001627223) (Subject)

      1/24/24 9:46:44 AM ET
      $CC
      Major Chemicals
      Industrials